RP1 rs11568815: Understanding This Genetic Variant
The rs11568815 variant is located within the RP1 gene, which plays a critical role in the structure and function of photoreceptor cells in the eye. While specific pathogenic mutations in this gene are well-documented causes of inherited retinal diseases, the clinical significance of this particular variant is currently limited.
What each genotype means
Typical retinal risk
You carry two copies of the common reference allele at this position in the RP1 gene. This genotype is not associated with RP1-related autosomal dominant retinitis pigmentosa. Your baseline risk for inherited retinal degeneration remains similar to that of the general population.
Carried by more than 99.9% of individuals across all major global populations.
Increased retinitis pigmentosa risk
You carry one copy of the rare variant allele associated with autosomal dominant retinitis pigmentosa. In published research, heterozygous carriers may experience progressive rod photoreceptor degeneration typically characterized by night blindness and peripheral visual field loss. Because clinical expression and severity can vary significantly among individuals, genetic counseling is recommended to discuss your family history and clinical context.
Extremely rare; observed in fewer than 1 in 10,000 individuals globally in large population databases such as gnomAD.
High retinitis pigmentosa risk
You carry two copies of the rare pathogenic variant allele in the RP1 gene. Autosomal dominant retinitis pigmentosa typically manifests with only a single altered copy, and homozygous occurrence is exceptionally documented, likely leading to severe or early-onset progressive retinal degeneration. An ophthalmology evaluation and formal clinical genetic consultation are recommended to assess retinal health and clarify findings.
Extremely rare to virtually absent in general population cohorts, estimated at far less than 1 in 1,000,000 individuals.
What is rs11568815 and Where is it Located?
The variant rs11568815 is a single nucleotide polymorphism (SNP) situated within the RP1 gene. This gene is located on the long arm of chromosome 8 (8q11.23-q12.1). In genomics, a SNP represents a variation at a single position in the DNA sequence among individuals. While many SNPs are common and have no impact on health, others are studied for their potential to influence biological processes or disease susceptibility. The RP1 gene is particularly notable in clinical genetics because it is a known site for mutations that can lead to retinal dystrophies. Researchers track variants like rs11568815 to determine if they contribute to the genetic architecture of vision-related conditions or if they are simply benign variations that occur naturally within the human population.
The Role of the RP1 Gene
The RP1 gene provides instructions for producing a protein that is essential for the proper function of photoreceptor cells—the specialized cells in the retina that detect light. This protein is a microtubule-associated protein, meaning it helps organize the internal structure of the photoreceptor's outer segment, which is vital for converting light into electrical signals sent to the brain. When the RP1 gene is disrupted by pathogenic mutations, it can lead to the production of a truncated or non-functional protein. This disruption often results in the progressive degeneration of rod and cone cells, a condition clinically recognized as retinitis pigmentosa. Because the protein is so specialized for retinal health, even minor changes in its sequence are often scrutinized by researchers to understand how they might affect the structural integrity of the eye.
Research and Evidence Strength
The evidence linking specific variants in the RP1 gene to retinal disease is strong, but it is important to distinguish between known pathogenic mutations and variants of uncertain significance like rs11568815. While pathogenic variants in RP1 are established causes of autosomal dominant and autosomal recessive retinitis pigmentosa, the specific association of rs11568815 with these conditions is currently limited. Scientific literature often highlights that RP1-related retinal dystrophies exhibit significant clinical heterogeneity, meaning the severity and age of onset can vary widely even among individuals with similar genetic profiles. Because the functional impact of rs11568815 is not fully characterized in peer-reviewed research, it is not currently classified as a primary driver of disease. Ongoing studies continue to map the mutational spectrum of the RP1 gene to better differentiate between benign polymorphisms and those that contribute to vision loss.
Population Frequency
The frequency of specific variants can vary significantly across different ancestral populations. For the rs11568815 variant, current data indicates that it is considered rare. In genetic research, rare variants are often those found in less than 1% of the general population. Because this variant is rare, it is difficult to draw broad conclusions about its prevalence across diverse global ancestries without larger, more comprehensive genomic datasets. Researchers rely on databases like gnomAD to estimate these frequencies, which helps in determining whether a variant is a common, benign feature of the human genome or a rare occurrence that warrants further clinical investigation. When a variant is rare, it is often harder to establish a clear statistical link to health outcomes, as there are fewer individuals available for study.
What You Can Do With This Information
Genetic information regarding variants like rs11568815 is primarily intended for educational and research purposes. It is crucial to understand that this information is not a medical diagnosis and cannot predict your personal health outcomes. If you have concerns about your vision or a family history of retinal disease, the most appropriate step is to consult with a healthcare professional, such as an ophthalmologist or a genetic counselor. They can provide context based on your specific clinical history, perform necessary diagnostic tests, and interpret genetic findings in a way that is relevant to your health. Avoid making medical decisions based solely on raw genetic data, as the interpretation of variants is a complex field that requires professional expertise and clinical correlation.
How common is this variant?
The rs11568815 variant is classified as rare, with its specific genotype frequencies varying across different ancestral groups.
Frequently asked questions
Is rs11568815 a cause of blindness?
There is no current evidence to suggest that rs11568815 is a direct cause of blindness. While other mutations in the RP1 gene are linked to retinal diseases, this specific variant is not established as pathogenic.
Should I get tested for RP1 variants?
Genetic testing for RP1 is typically reserved for individuals with a clinical diagnosis of retinal dystrophy or a strong family history. You should discuss the necessity of such testing with a medical geneticist or ophthalmologist.
What does it mean if a variant is 'rare'?
A rare variant is one that appears in a very small percentage of the population. Being rare does not automatically mean a variant is harmful; it simply means it is not a common feature of the human genetic code.
Can I change my genetic risk for retinal disease?
You cannot change your DNA sequence. However, maintaining regular eye exams and discussing your family history with a doctor can help in the early detection and management of potential eye health issues.
Sources & further reading
Educational information only, last refreshed 10/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11568815?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in RP1
Carries the Arg677STOP truncating mutation in RP1, accounting for up to 5% of autosomal dominant retinitis pigmentosa in European-derived populations.
Pathogenic nonsense truncating mutation (p.Arg677Ter) causing autosomal dominant retinitis pigmentosa.
A well-characterized missense substitution in RP1 implicated in inherited retinal degeneration and forms of retinitis pigmentosa.
Well-characterized nonsense/truncating variant in RP1 linked to autosomal dominant retinitis pigmentosa.
A nonsense variant (p.Arg677Ter) in RP1 causing autosomal dominant retinitis pigmentosa.
This variant in the RP1 gene is associated with autosomal dominant retinitis pigmentosa, causing progressive night blindness and peripheral field loss.